BRIEF published on 05/23/2025 at 10:05, 1 year 2 months ago The Platform Group AG annonce une forte croissance au premier trimestre 2025 Acquisitions Bénéfice Net Expansion Du Partenariat Croissance Du GMV T1 2025
BRIEF published on 05/23/2025 at 09:10, 1 year 2 months ago BioNxt Solutions Set to Receive European Patent for Drug Delivery System Drug Development Multiple Sclerosis European Patent BioNxt Solutions Sublingual Delivery
BRIEF published on 05/23/2025 at 09:10, 1 year 2 months ago BioNxt Solutions s'apprête à obtenir un brevet européen pour son système d'administration de médicaments Sclérose En Plaques Développement De Médicaments Solutions BioNxt Brevet Européen Administration Sublinguale
BRIEF published on 05/23/2025 at 09:05, 1 year 2 months ago Positive Outlook for NFON AG with Strategic Growth Initiatives Growth Strategy NFON AG Recurring Revenue Q1 Sales AI Initiatives
BRIEF published on 05/23/2025 at 09:05, 1 year 2 months ago Perspectives positives pour NFON AG avec des initiatives de croissance stratégique NFON AG Revenus Récurrents Stratégie De Croissance Ventes Du Premier Trimestre Initiatives En Matière D'IA
BRIEF published on 05/23/2025 at 09:05, 1 year 2 months ago Brödernas Group AB Postpones Annual Financial Statement Release Restructuring Process Financial Statement Delay Brödernas Group AB Richard Forsshéll Bonds Default
BRIEF published on 05/23/2025 at 09:05, 1 year 2 months ago Brödernas Group AB reporte la publication de ses états financiers annuels Groupe Brödernas AB Richard Forsshéll Processus De Restructuration Défaut De Paiement Des Obligations Retard Des États Financiers
BRIEF published on 05/23/2025 at 09:05, 1 year 2 months ago Alzchem Group AG Finalizes Succession Planning with New COO Appointment Chief Operating Officer Succession Planning Alzchem Group AG Specialty Chemicals Dr. Jürgen Sans
BRIEF published on 05/23/2025 at 09:05, 1 year 2 months ago Alzchem Group AG finalise sa planification de succession avec la nomination d'un nouveau directeur de l'exploitation Planification De La Relève Chef De L'exploitation Groupe Alzchem AG Produits Chimiques De Spécialité Dr Jürgen Sans
BRIEF published on 05/23/2025 at 09:05, 1 year 2 months ago Secarna Pharmaceuticals Unveils Promising SECN-15 Data at ASCO 2025 Cancer Therapy Clinical Trial Secarna Pharmaceuticals Antisense Oligonucleotide SECN-15
Published on 08/04/2026 at 22:30, 3 hours 13 minutes ago Nextech3D.ai Provides Update on Acquisition of Remaining ARway Shares
Published on 08/04/2026 at 17:00, 8 hours 43 minutes ago Moderna annonce le début d'un essai clinique de phase 1 portant sur l’ARNm-1469, son vaccin expérimental contre l'ébolavirus de Bundibugyo
Published on 08/04/2026 at 16:25, 9 hours 18 minutes ago ACCESS Newswire to Host Second Quarter Earnings Conference Call on August 11, 2026
Published on 08/04/2026 at 15:00, 10 hours 43 minutes ago Infield Minerals Expands Land Position at the Kings Canyon Gold Project in Utah
Published on 08/04/2026 at 22:03, 3 hours 39 minutes ago #FutureFresenius: Excellent Q2 performance demonstrates structural step-up – Guidance raised
Published on 08/04/2026 at 22:01, 3 hours 42 minutes ago EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius raises its earnings guidance for fiscal year 2026 due to strong operational business performance
Published on 08/04/2026 at 20:05, 5 hours 38 minutes ago Hard Rock Cafe and Coca-Cola® Launch Hard Rock Rising Music Competition for Emerging Artists
Published on 08/04/2026 at 19:39, 6 hours 3 minutes ago EQS-Adhoc: Basler AG financial results for the first 6 months of 2026: Strong business performance in the first half of the year; company raises its 2026 forecast once again
Published on 08/04/2026 at 18:32, 7 hours 10 minutes ago Capital et droits de vote au 31 juillet 2026
Published on 08/04/2026 at 18:32, 7 hours 10 minutes ago Total number of voting rights and shares making up the share capital at July 31, 2026
Published on 08/04/2026 at 17:45, 7 hours 58 minutes ago INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
